Feb. 5, 2025 — Researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a successful ...

During the hearing, Democrats including Warren raised concerns about Kennedy’s intention to keep a financial interest from major lawsuits against vaccine manufacturers. In the ethics statement ...

First chikungunya vaccine recommended by the CHMP for persons as young as 12 years old. The virus-like particle (VLP) single-dose chikungunya vaccine is expected to launch in key European markets ...

Sen. Bernie Sanders (I-Vermont) on Jan. 29 pressed Kennedy on whether he stands by merch sold by Children’s Health Defense Fund, an anti-vaccine organization founded by the nominee.

AH, BLHW, FK, HW, JB, JK, LEB, NW, SB, VD, and VG declare no competing interests. EN holds shares in Valneva, a vaccine company, issued during her employment which ended in July, 2024. FF is a member ...

By Teddy Rosenbluth Robert F. Kennedy Jr. has often trained his criticisms of vaccines on a common ingredient: aluminum, which he has suggested is responsible for a litany of childhood ailments ...

The hepatitis B vaccine is a shot, typically injected into the arm, that protects against hepatitis B in babies, children, and adults. It is an important way to protect yourself and your children from ...

Vaxxas has announced that the CEPI, has approved the progression of a $7.2 million program to develop heat-stable, dried-formulation mRNA vaccines delivered using Vaxxas’ needle-free high-density ...

Vaxxas will partner with leading global vaccine developer SK bioscience for the preclinical study to advance the company’s mRNA ... the potential for needle-free vaccination, reduction of ...

Robert F. Kennedy Jr., President Trump’s nominee to be health secretary, would have oversight power over the vaccine’s maker, Merck, if confirmed. By Christina Jewett and Sheryl Gay Stolberg ...

The news: Brisbane-based biotechnology company Vaxxas has secured approval from Coalition for Epidemic Preparedness Innovation (CEPI) to advance a $US4.8 million ($7. ...